Skip to main content
OpenTrials
Completed

NCT Number: NCT03271476

EMDR Psychotherapy to Treat Anxious-depressive Symptoms in Breast Cancer Patient

The study will consist in an adjustment/adaptation of the "standard EMDR protocol" for cancer disease, and most particulary for women who present a breast cancer and during adjuvant therapy. It will also test the faisability of the research, with a view to adjust the calendar and the ressources to put at disposal for a randomized control trial that follow. This study will also allow to test the need and acceptibility of this new psychotherapy for the patient, and to identify facilitators and obstacles : participation/rejection ratio, inclusion rythm, adhesion of the medical staff about the project

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Breast Cancer Breast Diseases Breast Neoplasms Eye Movement Desensitization and Processing Neoplasms Neoplasms by Site Psychoterapy Skin Diseases Skin and Connective Tissue Diseases

Age range

18 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

CHR Metz-Thionville

Metz, 57085, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Being a woman aged of 18 years or more
  • Having a primary invasive breast cancer
  • Having undergo a mastectomy for a primary invasive breast cancer
  • Being able to complete the questionnaires
  • Being informed of the study and having signed the informed consent
  • Being affiliated to a welfare system

Exclusion criteria

  • having contraindications to recieve EMDR psychotherapy (neurologic disorders, dissociatif states, oculomotor issues)
  • Having started adjuvant treatments following surgery
  • Having metastatic breast cancer
  • Presenting physical polypathologies
  • Having psychiatric antecedents (included anxiety and depressif disorders - assessed with M.I.N.I. (Sheehan and al., 1997)).
  • Having drug or alcohol addiction
  • Being placed under the safeguard of justice, guardianship or trusteeship
  • Being pregnant or breast-feeding

Treatment and study plan

EMDR psychotherapy

Behavioral

Visit 0 : patient inclusion (questionnaires and interview) Visit 1 : anamnesis Visit 2 : patient supporting Visit 3 : EMDR psychotherapy care Visit 4 : EMDR psychotherapy care Visit 5 : EMDR psychotherapy care and questionnaires Visit 6 : EMDR psychotherapy care Visit 7 : EMDR psychotherapy care Visit 8 : EMDR psychotherapy care ans questionnaires Visit 9 (one month after) : semi-directive interview and data recovery (questionnaires)

Primary outcomes

  1. patients involvement

    Time frame: week 12

    acceptability of the new psychotherapy

Secondary outcomes

  1. adequacy of the intervention with the field

    Time frame: Week 12

    adaptability of the EMDR protocol

  2. EMDR psychotherapy efficacy during the study, we will survey our population several times with differents questionnaires

    Time frame: Week 12

    ratio of patients which wants to participate and effectively participate

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Régional Metz-Thionville

Other

Collaborators

  • University of Lorraine

Registry information

Official study title

EMDR Psychotherapy of Anxious-depressive Symptoms for Women That Present an Invasive Beast Cancer : a Faisability Study

Acronym: PSYCANCER

Important dates

Study start
2017
Primary completion
2018
Study completion
2018
First posted
Sep 5, 2017
Registry last updated
Jun 25, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.